ASSESSMENT OF BIOTECHNOLOGICAL POTENTIAL OF MICROORGANISMS CULTURES PROMISSING FOR SUPRESSING ANTIBIOTIC-RESISTANT STRAINS
Main Article Content
Authors
Abstract
One of the problems in global practical medicine is antibiotic-resistant strains. The problem is that pathogens are resistant to a number of antibacterial drugs and this makes treatment difficult, which can be long and/or ineffective. One solution is to develop drugs based on bacterial lysates. In this article, the objects of study are producers of extended spectrum β-lactamases - Enterobacteriaceae, Acinetobacter, Pseudomonas, Staphylococcus, Haemophilus, Streptococcus. We assessed the survival, antibiotic resistance and biological compatibility of 25 microbial cultures. Cultures have acceptable viability numbers reguired for industrially valuable strains: more than 106 CFU/ml (109 – 1010 CFU/ml). Antibiotic resistance to various groups of is antibiotics was studied: carbapenems, fluoroguinolones, cephalosporins, macrolides, aminoglycosides, penicillins, chloramphenicols. The choise of antibacterial drugs is based on the freguent use of these antibiotics. The spectrum of antibiotic resistance of each strain is different, from one antibiotic (Ps. aeruginosa 13) to ten antibiotics (S. pneumoniae 5). Cultures are resistant to amoxicillin, ampicillin, benzylpenicillin, erythromycin and cephalosporins. The strains are mostly biocompatible with each other and have antibiotic resistance to a number of antibacterial drugs.
Keywords
штамм, чистая культура, реактивация, жизнеспособность, хранение, лизат
Article Details
References
Ruslanyly K., Urakova A.D., Israilova V. K. Informativnost' naseleniya goroda Almaty ob ugroze antibiotikorezistentnosti // Vestn. KazNMU. - 2018. - № 3. - S. 297-301.
Giuseppe Mancuso, Angelina Midiri, Elisabetta Gerace et al. Bacterial Antibiotic Resistance: The Most Critical Pathogens // Pathogens. – 2021. – Vol. 10 (10), P. 1310-1313. 10.3390/pathogens10101310 (Accessed: 11.03.2024).
Boucher H.W., Talbot G.H., Bradley J.S. et al. Bad Bugs, No Drugs: No ESKAPE! An update from the Infectious Diseases Society of America // Clin Infect Dis. - 2009. - 48 (1), Р. 1-12. URL (Accessed: 29.03.2024).
Beisegulova G. N., Ramazanova B. A., Mustafina K. K. i dr. Antibiotikorezistentnost' shtammov S. pneumoniae, tsirkuliruyushch v g. Almaty, na fone provodimoi vseobshchei immunizstsii // Vestn. KazNMU. – 2022. - № 1. – S. 103-109.
Sarsekeeva A. S., Zhumagalieva A. N., Frolova M. Yu. Problema antibiotikorezistentnosti osnovnykh vozbuditelei vnebolnichnoi pnevmonii I puti ee preodoleniya // Nauka I zdravookhranenie. - 2014. - № 1. - S. 57-59.
Bisenova N. M., Yergalieva A. S., Mitus N. M. Rezistentnost' gramotritsatelnykh bakterii v otdelenii reanimatii // J. of Clinical Medicine of Kazakhstan. - 2016. – Vol. 4, № 42. – S. 46-51.
Kulzhanova Sh. A., Turebaeva G. O. Antibiotikorezistentnost' shigel na sovremennom etape // Science & Healthcare. - 2019. - Vol. 21, № 1. – S. 74-79.
Rozy A. Chorostowska-Wynimko J. Bacterial immunostimulants-mechanism of action and clinical application in respiratory diseases // Pneumonol Alergol Pol. – 2008. - Vol. 76, Р. 353-359.
Rukovodstvo k prakticheskim zanyatiyam po mikrobiologii // Pod red. N. S. Yegorova. – M.: Moskovskii Universitet, 1995. – 220 s.
Spravochnik po mikrobiologicheskim I virusologicheskim metodam issledovaniya // Pod red. M. O. Birger. – M.: Meditsina, 1982. – 462 s. - S. 63-64.
Opredelenie chuvstvitel'nosti mikroorganizmov k antibakterial'nym preparatam. Metodicheskie ukazaniya: MUK 4.2.1890-04. - Moskva, 2004. – 90 s.
Irkitova A. N., Kagan Ya. R. Metody opredeleniya antagonisticheskoi aktivnosti molochnokislykh bakterii // Aktual'nye problemy tekhniki I tekhnologii pererabotki moloka. - 2012. - № 9. – S. 226-236/
Funk I. A., Irkitova A. N. Otsenka antagonisticheskoi aktivnosti kollektsionnych shtammov Lactobacillus plantarum // Acta Biologiсa Sibirica. – 2015. - № 1-2. – S. 85-93.
Vil'yams D. Rezistentnost' k beta-laktamnym preparatam // Antibiotiki I khimioterapiya. - 1997. - № 4. - S. 4-6.
Macchi A., Vecchia L.D. Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections // Arzneimittelforschung. - 2005. - Vol. 55, № 5. - P. 276-281. doi: 10.1055/s-0031-1296857